Third Wave, Chiron, Bayer dismiss HCV patent suit
CHICAGO (Reuters) – Third Wave Technologies Inc. on
Thursday said it reached an agreement with Chiron Corp. and
Bayer Corp. to dismiss its lawsuit against Chiron and Bayer
over patents related to hepatitis C virus, or HCV.
Terms of the agreement were not disclosed.
Madison, Wisconsin-based Third Wave said no licenses were
granted or taken under the agreement and no payment was made to
any of the companies.
It said it has now resolved all of its patent-related
lawsuits, with the exception of its ongoing dispute with